Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)

Recruiting now

Conditions studied: Myeloproliferative Neoplasm

In brief

The creation of a national database will provide access to solid data on the diagnosis of myeloproliferative neoplasia for patients under 30, giving a true picture of their care. It will also make it possible to identify the biological samples (histological and molecular) available in routine laboratories, enabling teams of researchers and anatomopathologists to (re)perform certain analyses to re-evaluate diagnoses and search for hitherto unknown molecular prognostic factors.

Key facts

Study ID

NCT06715267

Run by

University Hospital, Brest

People needed

200

Starts

2023-04-01

Expected to finish

2038-04-01

Last updated by the study team

2024-12-04

Who can join

Age: any, up to 30. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient diagnosed with non-LMC MPN before the age of 30 (PV or TE or MFP or PreMF) according to the 2016 WHO criteria.
• Signature of the consent form for participation in the FIMBANK project.
• Agreement to participate in the VYP study.
• Patient of legal age at the time of inclusion in VYP.
• Patient affiliated to a social security scheme

You may not qualify if…

• Refusal to participate by patients of full age
• Patient under legal protection (guardianship, curatorship, etc.)

Where it is running

• CHU de Brest — Brest, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.